Stone disease has a multifactorial etiology involving heredity, lifestyle, and dietary factors. Providing patients with recommendations for the prevention and control of kidney stone formation is integral to decreasing the prevalence of stones and their associated costs.1
To optimize patient care, our kidney stone services help identify metabolic and physical compositions. Our comprehensive approach and concise report enable accurate interpretation to guide clinical decisions.
1 in 11
1 in 11 people in the United States are affected by kidney stones at least once in their lifetime2
60%–80% of patients with stone events will have recurrent episodes later in life3
90,000 kidney stones analyzed annually at Mayo Clinic Laboratories
Fill out the form below and one of our specialists will be in touch.